Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection
5. Conclusions
SARS-CoV-2 continues to pose a significant public health emergency globally. In the current study, the test agent nasal spray has been shown to significantly reduce SARS-CoV-2 infections in healthcare workers, with 62% fewer infections when compared to placebo.
5. Conclusions
SARS-CoV-2 continues to pose a significant public health emergency globally. In the current study, the test agent nasal spray has been shown to significantly reduce SARS-CoV-2 infections in healthcare workers, with 62% fewer infections when compared to placebo.

Comment